Treating Life-Threatening Bleedings

Development of Recombinant Coagulation Factor VIIa

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology
Cover of the book Treating Life-Threatening Bleedings by Ulla Hedner, Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Ulla Hedner ISBN: 9780128124406
Publisher: Elsevier Science Publication: July 4, 2017
Imprint: Academic Press Language: English
Author: Ulla Hedner
ISBN: 9780128124406
Publisher: Elsevier Science
Publication: July 4, 2017
Imprint: Academic Press
Language: English

Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa provides a comprehensive understanding of the first new drug within the area of hemostasis, describing a new mechanism of action that has resulted in a modified concept of the whole hemostasis mechanism. As the treatment of life-threatening bleedings is a serious challenge for clinicians, this powerful and historic case study presents a detailed roadmap on how a new medicine can be developed, stressing the interaction between science and clinical work.

The book stresses the importance of patient care in the learning process and provides new ideas on how to approach diseases and their treatment. Users will find a real world example that will act as a timely resource for those learning about, or engaged in, performing and supervising research across the biomedical sciences.

  • Documents the successful roadmap of the development of a new concept of treating major bleedings in the most life-threatening situations
  • Stresses the importance of the close connection between the clinic and research, describing how a new concept of hemostasis was revealed by careful clinical observation
  • Offers real-world research and development context for drug discovery, and for the treatment of hemophilia and other bleeding disorders
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa provides a comprehensive understanding of the first new drug within the area of hemostasis, describing a new mechanism of action that has resulted in a modified concept of the whole hemostasis mechanism. As the treatment of life-threatening bleedings is a serious challenge for clinicians, this powerful and historic case study presents a detailed roadmap on how a new medicine can be developed, stressing the interaction between science and clinical work.

The book stresses the importance of patient care in the learning process and provides new ideas on how to approach diseases and their treatment. Users will find a real world example that will act as a timely resource for those learning about, or engaged in, performing and supervising research across the biomedical sciences.

More books from Elsevier Science

Cover of the book Advances in Parasitology by Ulla Hedner
Cover of the book Groovy Programming by Ulla Hedner
Cover of the book Control of Plant Virus Diseases by Ulla Hedner
Cover of the book Lifestyle Medicine by Ulla Hedner
Cover of the book Advances in Quantum Chemistry by Ulla Hedner
Cover of the book Fundamentals of Optical Waveguides by Ulla Hedner
Cover of the book Conversations with Leading Academic and Research Library Directors by Ulla Hedner
Cover of the book Biological Inorganic Chemistry by Ulla Hedner
Cover of the book Plastic Analysis and Design of Steel Structures by Ulla Hedner
Cover of the book Hybrid Membrane Systems for Water Purification by Ulla Hedner
Cover of the book Nuclear and Radiochemistry by Ulla Hedner
Cover of the book Vertex Operator Algebras and the Monster by Ulla Hedner
Cover of the book Information Visualization by Ulla Hedner
Cover of the book Pressure Retarded Osmosis by Ulla Hedner
Cover of the book Non-Thermal Plasma Technology for Polymeric Materials by Ulla Hedner
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy